20Slash20 Inc., the creator of The Eye Drink, announced that it will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, scheduled for September 9–10, 2026, in New York City. The company's CEO, Dr. Roger Wu, will deliver an investor presentation on September 9 at 9:35 a.m. ET at The Westin New York Grand Central, and will also hold one-on-one meetings with investors. This conference is designed to bring together growth companies, investors, and industry professionals across life sciences and other emerging sectors.
The Eye Drink is described as the world's first ready-to-drink functional beverage specifically formulated with science-backed ingredients to support eye health for individuals who spend extended periods on phones and computers. As digital device usage continues to rise globally, the potential strain on eye health has become a growing concern, making this product timely. The company's participation in this conference underscores its commitment to addressing this modern health issue and attracting investment to further its mission.
InvestorWire, a specialized communications platform focused on wire-grade press release syndication, distributed the announcement. InvestorWire is one of over 75 brands within the Dynamic Brand Portfolio at IBN, which offers a range of services including access to a vast network of wire solutions, article and editorial syndication to 5,000+ outlets, enhanced press release distribution, social media distribution, and tailored corporate communications solutions. This platform aims to help private and public companies reach a wide audience of investors, influencers, consumers, journalists, and the general public.
The conference presentation by 20Slash20 is significant for investors and the beverage industry. It highlights the company's strategy to capitalize on the growing market for functional beverages, particularly those targeting eye health. With many people working long hours on screens, the demand for convenient, health-oriented beverages is on the rise. The Eye Drink positions itself as a convenient and tasty solution to support eye health in a screen-centric world.
The Moody Capital Solutions conference provides a platform for 20Slash20 to showcase its product to potential investors and industry professionals. This exposure could lead to partnerships, funding, and increased brand recognition. For the broader industry, the company's participation signals a trend toward specialized functional beverages that address specific health concerns beyond general wellness.
For more information about 20Slash20 and its products, interested parties are encouraged to review the full press release available at https://ibn.fm/tm2lT. Additional details about InvestorWire and its services can be found at https://www.InvestorWire.com, and the terms of use and disclaimers are available at https://www.InvestorWire.com/Disclaimer.
